Laughing Water Capital highlights Theravance Biopharma as a special situation with significant upside potential. Read the ...
Fapon Biopharma, a clinical-stage biotech company innovating therapeutic antibodies and fusion proteins, is pleased to announce its participation in the AACR Annual Meeting 2026, taking place April 19 ...
DuPont (NYSE:DD) today announced the launch of DuPont™ Liveo™ Pharma TPE Overmolded Assemblies, engineered for ultrapure fluid transfer across upstream and downstream pharmaceutical and ...
Company secures Commitment Letter from a leading financial institution of up to $22.5M to finance proposed acquisition ...
As AI accelerates across biopharma and other science-driven industries, organizations are encountering a critical bottleneck: ...
With this transaction, Biogen now owns exclusive worldwide development and commercialization rights to felzartamab, consolidating global rights ...
Meridian Funds, managed by ArrowMark Partners, released its first-quarter 2026 investor letter for “Meridian Small Cap Growth ...
1don MSN
Biogen buys China rights to immune disease drug in up to $850 million deal with TJ Biopharma
April 20 (Reuters) - Biogen said on Monday it had agreed to pay up to $850 million to acquire exclusive rights in Greater ...
Gilead, AstraZeneca and Vertex have acquired more than just a therapeutic asset in recent deals. BioSpace takes a look at ...
Elite Ultra-Marathoner targets her second World Record in two months following historicUltra Jackpot 100 Win ESTERO, FL ...
In 2026, AI will gain traction in life sciences and biopharmaceuticals, but the key to success is AI that goes deep into the ...
View Mereo BioPharma Group plc Sponsored ADR MREO stock quote prices, financial information, real-time forecasts, and company news from CNN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results